Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

The influence of silicone oil used in ophthalmology on the proton therapy of uveal melanomas.

Weber A, Cordini D, Stark R, Heufelder J.

Phys Med Biol. 2012 Dec 21;57(24):8325-41. doi: 10.1088/0031-9155/57/24/8325. Epub 2012 Nov 30.

PMID:
23201749
2.

Attenuation of iodine 125 radiation with vitreous substitutes in the treatment of uveal melanoma.

Oliver SC, Leu MY, DeMarco JJ, Chow PE, Lee SP, McCannel TA.

Arch Ophthalmol. 2010 Jul;128(7):888-93. doi: 10.1001/archophthalmol.2010.117.

PMID:
20625051
3.

Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.

Weber DC, Bogner J, Verwey J, Georg D, Dieckmann K, Escudé L, Caro M, Pötter R, Goitein G, Lomax AJ, Miralbell R.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):373-84.

PMID:
16168832
4.

[Endoresection following proton beam irradiation of large uveal melanomas].

Bechrakis NE, Höcht S, Martus P, Kreusel KM, Heese J, Foerster MH.

Ophthalmologe. 2004 Apr;101(4):370-6. German.

PMID:
15067418
5.

Monte Carlo calculations and measurements of absorbed dose per monitor unit for the treatment of uveal melanoma with proton therapy.

Koch N, Newhauser WD, Titt U, Gombos D, Coombes K, Starkschall G.

Phys Med Biol. 2008 Mar 21;53(6):1581-94. doi: 10.1088/0031-9155/53/6/005. Epub 2008 Feb 25.

6.

Iodine 125 brachytherapy with vitrectomy and silicone oil in the treatment of uveal melanoma: 1-to-1 matched case-control series.

McCannel TA, McCannel CA.

Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):347-52. doi: 10.1016/j.ijrobp.2014.02.021. Epub 2014 Apr 7.

PMID:
24721588
7.

Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma.

Tran BK, Schalenbourg A, Bovey E, Zografos L, Wolfensberger TJ.

Retina. 2013 Oct;33(9):1777-83. doi: 10.1097/IAE.0b013e318295f758.

PMID:
23792487
8.

Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.

Sikuade MJ, Salvi S, Rundle PA, Errington DG, Kacperek A, Rennie IG.

Eye (Lond). 2015 Sep;29(9):1194-8. doi: 10.1038/eye.2015.109. Epub 2015 Jul 10.

9.

Salvage proton beam therapy in local recurrent uveal melanoma.

Riechardt AI, Cordini D, Dobner B, Seibel I, Gundlach E, Rehak M, Hager A, Stark R, Moser L, Joussen AM.

Am J Ophthalmol. 2014 Nov;158(5):948-56. doi: 10.1016/j.ajo.2014.07.013. Epub 2014 Jul 16.

PMID:
25038327
10.

Use of high-frequency ultrasound imaging to improve delineation of anterior uveal melanoma for proton irradiation.

Daftari I, Barash D, Lin S, O'Brien J.

Phys Med Biol. 2001 Feb;46(2):579-90.

PMID:
11229735
11.

[Report on the conservative treatment of melanoma of the uvea at the Lausanne University Ophthalmologic Clinic].

Zografos L, Gailloud C, Perret C, Uffer S, Raimondi S, Chamot L, Carrel S, Greiner R.

Klin Monbl Augenheilkd. 1988 May;192(5):572-8. French.

PMID:
3404968
12.

The effects of intraocular silicone oil placement prior to iodine 125 brachytherapy for uveal melanoma: a clinical case series.

Ahuja Y, Kapoor KG, Thomson RM, Furutani KM, Shultz RW, Stafford SL, Dev S, Abu-Yaghi NE, Reynolds D, Pulido JS.

Eye (Lond). 2012 Nov;26(11):1487-9. doi: 10.1038/eye.2012.158. Epub 2012 Aug 31.

13.

Monte Carlo comparison of x-ray and proton CT for range calculations of proton therapy beams.

Arbor N, Dauvergne D, Dedes G, Létang JM, Parodi K, Quiñones CT, Testa E, Rit S.

Phys Med Biol. 2015 Oct 7;60(19):7585-99. doi: 10.1088/0031-9155/60/19/7585. Epub 2015 Sep 17.

PMID:
26378805
15.

Improved calibration of mass stopping power in low density tissue for a proton pencil beam algorithm.

Warren DR, Partridge M, Hill MA, Peach K.

Phys Med Biol. 2015 Jun 7;60(11):4243-61. doi: 10.1088/0031-9155/60/11/4243. Epub 2015 May 14.

PMID:
25973866
16.

Range verification for eye proton therapy based on proton-induced x-ray emissions from implanted metal markers.

La Rosa V, Kacperek A, Royle G, Gibson A.

Phys Med Biol. 2014 Jun 7;59(11):2623-38. doi: 10.1088/0031-9155/59/11/2623. Epub 2014 May 1.

PMID:
24786372
17.

Proton beam irradiation of uveal melanomas. Results of 5 1/2-year study.

Gragoudas ES, Goitein M, Verhey L, Munzenreider J, Urie M, Suit H, Koehler A.

Arch Ophthalmol. 1982 Jun;100(6):928-34.

PMID:
6284097
18.

Pathologic examination of ciliary body melanoma treated with proton beam irradiation.

Ferry AP, Blair CJ, Gragoudas ES, Volk SC.

Arch Ophthalmol. 1985 Dec;103(12):1849-53.

PMID:
3000326
19.

Dosimetric impact of tantalum markers used in the treatment of uveal melanoma with proton beam therapy.

Newhauser WD, Koch NC, Fontenot JD, Rosenthal SJ, S Gombos D, Fitzek MM, Mohan R.

Phys Med Biol. 2007 Jul 7;52(13):3979-90. Epub 2007 Jun 6.

PMID:
17664589
20.

A simulation study on proton computed tomography (CT) stopping power accuracy using dual energy CT scans as benchmark.

Hansen DC, Seco J, Sørensen TS, Petersen JB, Wildberger JE, Verhaegen F, Landry G.

Acta Oncol. 2015;54(9):1638-42. doi: 10.3109/0284186X.2015.1061212. Epub 2015 Jul 29.

PMID:
26219959

Supplemental Content

Support Center